^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Drug: | sorafenib (Multi-tyrosine kinase inhibitor, pan-RAF inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/28/2021
Excerpt:
Soft Tissue Sarcoma: Preferred Regimens...Sorafenib (category 1)
